Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours.
about
Dosimetry of [(177)Lu]-DO3A-VS-Cys(40)-Exendin-4 - impact on the feasibility of insulinoma internal radiotherapy.High-throughput high-volume nuclear imaging for preclinical in vivo compound screening§Positron emission tomography imaging of tumor angiogenesis and monitoring of antiangiogenic efficacy using the novel tetrameric peptide probe 64Cu-cyclam-RAFT-c(-RGDfK-)4.Influence of tumour size on the efficacy of targeted alpha therapy with (213)Bi-[DOTA(0),Tyr(3)]-octreotateMolecular-targeted approaches to reduce renal accumulation of nephrotoxic drugs.Treatment of gastroenteropancreatic neuroendocrine tumors with peptide receptor radionuclide therapy.Radionuclide therapy via SSTR: future aspects from experimental animal studies.Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.Metal-Based PSMA Radioligands.Reduction of renal uptake of 111In-DOTA-labeled and A700-labeled RAFT-RGD during integrin αvβ3 targeting using single photon emission computed tomography and optical imaging.Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.Novel peptide probes to assess the tensional state of fibronectin fibers in cancer.177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Borderline Low and Discordant Renal Parameters: Treatment Feasibility Assessment by Sequential Estimation of Triple Parameters and Filtration Fraction.Gelofusine Ameliorates Colistin-Induced Nephrotoxicity.Protective effect of Gelofusine against cRGD-siRNA-induced nephrotoxicity in mice.
P2860
Q35402008-9ACCEAE6-5B3B-48ED-842A-E32831AE68B2Q36340673-4585E829-0222-4076-A9B2-12C54049015EQ36394255-0FBC8D29-E974-4D99-B120-41F334BC2148Q36484229-700F242D-E7CD-40A8-A8F8-8CC1E75939B6Q37763924-4029F03D-0234-41E8-A154-5B4B468F5AFAQ37975101-3DFD05EB-CBAD-4D87-84AA-E317B5A417C3Q38008839-C8777E40-4D07-4318-80E6-23D62F0A8A40Q38230884-93295865-C545-4081-941F-4368AD52372DQ39198527-E5EF096C-3A09-430F-B4CA-AF4EC84AAC0AQ39373913-F75EAE91-3E50-425E-93DF-B032749D7294Q39376122-DCF4161F-6623-4ABD-9D9C-758322ED8B9DQ47117973-CD89098E-0A47-4031-AFF6-8FBC6BBF435CQ49176798-062672AF-2697-42E7-B0AE-5776360B1CD0Q50035129-5391019A-DEFF-47B7-BC14-72C3AA10D175Q52605511-719D213D-1373-4FE3-B91B-80BB66B88B48
P2860
Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Dose-response effect of Gelofu ...... in rats with CA20948 tumours.
@en
Dose-response effect of Gelofu ...... in rats with CA20948 tumours.
@nl
type
label
Dose-response effect of Gelofu ...... in rats with CA20948 tumours.
@en
Dose-response effect of Gelofu ...... in rats with CA20948 tumours.
@nl
prefLabel
Dose-response effect of Gelofu ...... in rats with CA20948 tumours.
@en
Dose-response effect of Gelofu ...... in rats with CA20948 tumours.
@nl
P2093
P2860
P1476
Dose-response effect of Gelofu ...... in rats with CA20948 tumours.
@en
P2093
Edgar J Rolleman
Eric P Krenning
Jan de Swart
Magda Bijster
Marion de Jong
Mark W Konijnenberg
Marleen Melis
Monique de Visser
P2860
P2888
P304
P356
10.1007/S00259-009-1196-8
P577
2009-12-01T00:00:00Z